198 related articles for article (PubMed ID: 2427685)
1. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Greenberg DA; Carpenter CL; Messing RO
J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
[TBL] [Abstract][Full Text] [Related]
2. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes.
Kamp TJ; Sanguinetti MC; Miller RJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
Kunze DL; Hamilton SL; Hawkes MJ; Brown AM
Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436
[TBL] [Abstract][Full Text] [Related]
6. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
[TBL] [Abstract][Full Text] [Related]
7. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
Liu J; Bangalore R; Rutledge A; Triggle DJ
Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
Rampe D; Poder T; Zhao ZY; Schilling WP
J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
[TBL] [Abstract][Full Text] [Related]
9. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
10. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
11. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
Kokubun S; Prod'hom B; Becker C; Porzig H; Reuter H
Mol Pharmacol; 1986 Dec; 30(6):571-84. PubMed ID: 2431263
[TBL] [Abstract][Full Text] [Related]
12. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
13. Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells.
Lee RT; Smith TW; Marsh JD
Circ Res; 1987 May; 60(5):683-91. PubMed ID: 2439230
[TBL] [Abstract][Full Text] [Related]
14. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
15. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the number of functional voltage-sensitive Ca++ channels on PC12 cells by chronic changes in membrane potential.
DeLorme EM; Rabe CS; McGee R
J Pharmacol Exp Ther; 1988 Mar; 244(3):838-43. PubMed ID: 2855244
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
18. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
Pauwels PJ; Van Assouw HP; Leysen JE
Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992
[TBL] [Abstract][Full Text] [Related]
19. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
Bellemann P; Ferry D; Lübbecke F; Glossman H
Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
[TBL] [Abstract][Full Text] [Related]
20. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
Morel N; Godfraind T
J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
